奥美拉唑、铝碳酸镁、莫沙比利联合治疗胃食管反流病疗效分析

Omeprazole,Aluminum Magnesium Carbonate and Mosapride in the Treatment of Gastroesophageal Reflux

目的：探讨胃食管反流病采用奥美拉唑、莫沙比利、铝碳酸镁联合治疗价值。方法选取胃食管反流病80例，均为我院2013年5月～2015年5月收治，随机分组，就奥美拉唑单用治疗（对照组，n=40）与奥美拉唑、莫沙必利、铝碳酸镁联合治疗（观察组，n=40）效果展开对比。结果观察组选取的胃食管反流病患者总有效率为95%，明显高于对照组70%，有统计学差异（P＜0.05）。两组均无明显不良反应。结论针对胃食管反流病的患者，采用奥美拉唑、莫沙比利、铝碳酸镁治疗，可显著提高临床治疗效果，且无明显不良反应，对保障患者生存质量意义显著。

Objective Discussion gastroesophageal reflux disease omeprazole, mosapride, hydrotalcid joint therapeutic value.Methods Select gastroesophageal reflux disease, 80 cases were hospital from May 2013 to May 2015 were treated, randomized to omeprazole treatment alone （control group, n = 40） and omeprazole, MO cisapride, aluminum magnesium combination therapy （study group, n = 40） expand contrast effect.ResultsObservation group selected GERD patients, the total effective rate was 95%, significantly higher than 70%, a significant difference （P〈0.05）. There were no significant adverse reactions.Conclusion For patients with GERD, omeprazole, mosapride, aluminum magnesium carbonate treatment, can significantly improve the clinical treatment, and no significant adverse reactions, meaning to protect the quality of life of patients significantly.